Filing Details
- Accession Number:
- 0001140361-11-029098
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-05-20 16:37:27
- Reporting Period:
- 2011-05-18
- Filing Date:
- 2011-05-20
- Accepted Time:
- 2011-05-20 16:37:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 350907 | Thoratec Corp | THOR | Electromedical & Electrotherapeutic Apparatus (3845) | 942340464 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1248380 | F Neil Dimick | 6035 Stoneridge Drive Pleasanton CA 94588 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2011-05-18 | 375 | $33.21 | 33,580 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2011-05-19 | 250 | $35.00 | 33,330 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2011-05-20 | 625 | $35.66 | 32,705 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Shares of Common Stock sold pursuant to a Sales Plan established by the Reporting Person on May 3, 2010, which Sales Plan is intended to comply with the requirements of Rule 10b5-1(c)(1) under the Securities Exchange Act 1934, as amended.
- This transaction was executed in multiple trades in prices ranging from $33.00 to $33.57. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades in prices ranging from $35.43 to $35.82. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
